Vimarsana
Biggest News Aggregation in the World

Zita Plus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zita Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zita Plus Today - Breaking & Trending Today

Glenmark launches Triple FDC of Teneligliptin + Pioglitazone + Metformin for Adults with Type 2 Diabetes & High Insulin Resistance - Vimarsana News

Glenmark launches Triple FDC of Teneligliptin + Pioglitazone + Metformin for Adults with Type 2 Diabetes & High Insulin Resistance

Published: December 21, 2022

Glenmark Pharmaceuticals Limited, an innovation-driven, global pharmaceutical company has launched the first triple fixed-dose combination Teneligliptin with Pioglitazone and Metformin in India.

Source: equitybulls.com
Related Topics:
Remogliflozin RemoVildagliptin RemoSitagliptin SitazitAlok MalikDapagliflozin ZitaPioglitazone Zita PioGlenmark Pharmaceuticals LimitedGlenmark PharmaceuticalsInternational Diabetes FederationGlenmark Pharmaceuticals LtdHigh InsulinPharmaceuticals LimitedDipeptidyl PeptidaseZita PlusZita Met PlusZita Pio
Glenmark is the first company to launch in India a Triple FDC of Teneligliptin + Pioglitazone + Metformin for Adults with Type 2 Diabetes & High Insulin Resistance - Vimarsana News

Glenmark is the first company to launch in India a Triple FDC of Teneligliptin + Pioglitazone + Metformin for Adults with Type 2 Diabetes & High Insulin Resistance

Published: December 21, 2022

Stay connected with Business News This Week for business news, news this week, news headlines, business news, health, education, startups

Source: businessnewsthisweek.com
Related Topics:
Remogliflozin RemoVildagliptin RemoSitagliptin SitazitAlok MalikDapagliflozin ZitaPioglitazone Zita PioGlenmark Pharmaceuticals LimitedInternational Diabetes FederationGlenmark Pharmaceuticals LtdDipeptidyl PeptidaseIndia FormulationsZita PlusZita Met PlusZita Pio